{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:13:52Z","timestamp":1786443232628,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-024-01991-5","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T01:04:27Z","timestamp":1739927067000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Intranasal dupilumab improves responsiveness to steroid in an asthma mouse model"],"prefix":"10.1007","volume":"74","author":[{"given":"Baraa","family":"Khalid Salah Al-Sheakly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Saheb Sharif-Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjes","family":"Saheb Sharif-Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel M.","family":"Zakri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Mdkhana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Wed Abdelaziz Eladham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Hundt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Hachim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabih","family":"Halwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"1991_CR1","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1183\/09031936.93.06050743","volume":"6","author":"AJ Woolcock","year":"1993","unstructured":"Woolcock AJ. Steroid resistant asthma: what is the clinical definition? Eur Respir J. 1993;6:743\u20137.","journal-title":"Eur Respir J"},{"key":"1991_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/0091-6749(92)90144-q","volume":"90","author":"AK Kamada","year":"1992","unstructured":"Kamada AK, Leung DY, Gleason MC, Hill MR, Szefler SJ. High-dose systemic glucocorticoid therapy in the treatment of severe asthma: a case of resistance and patterns of response. J Allergy Clin Immunol. 1992;90:685\u20137. https:\/\/doi.org\/10.1016\/0091-6749(92)90144-q.","journal-title":"J Allergy Clin Immunol"},{"key":"1991_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.7326\/0003-4819-127-2-199707150-00009","volume":"127","author":"ER McFadden Jr","year":"1997","unstructured":"McFadden ER Jr, Warren EL. Observations on asthma mortality. Ann Intern Med. 1997;127:142\u20137. https:\/\/doi.org\/10.7326\/0003-4819-127-2-199707150-00009.","journal-title":"Ann Intern Med"},{"key":"1991_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/nejm198602133140706","volume":"314","author":"SR Benatar","year":"1986","unstructured":"Benatar SR. Fatal asthma. N Engl J Med. 1986;314:423\u20139. https:\/\/doi.org\/10.1056\/nejm198602133140706.","journal-title":"N Engl J Med"},{"key":"1991_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/164_2016_62","volume":"237","author":"PJ Barnes","year":"2017","unstructured":"Barnes PJ. Glucocorticosteroids. Handb Exp Pharmacol. 2017;237:93\u2013115. https:\/\/doi.org\/10.1007\/164_2016_62.","journal-title":"Handb Exp Pharmacol"},{"key":"1991_CR6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.5114\/aoms.2012.30280","volume":"8","author":"J Mathew","year":"2012","unstructured":"Mathew J, Aronow WS, Chandy D. Therapeutic options for severe asthma. Arch Med Sci. 2012;8:589\u201397. https:\/\/doi.org\/10.5114\/aoms.2012.30280.","journal-title":"Arch Med Sci"},{"key":"1991_CR7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.anai.2021.01.012","volume":"126","author":"TM Laidlaw","year":"2021","unstructured":"Laidlaw TM, et al. Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma. Ann Allergy Asthma Immunol. 2021;126:584-592.e581. https:\/\/doi.org\/10.1016\/j.anai.2021.01.012.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1991_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cea.13491","volume":"50","author":"H Harb","year":"2020","unstructured":"Harb H, Chatila TA. Mechanisms of dupilumab. Clin Exp Allergy. 2020;50:5\u201314. https:\/\/doi.org\/10.1111\/cea.13491.","journal-title":"Clin Exp Allergy"},{"key":"1991_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.molmed.2004.08.004","volume":"10","author":"TA Chatila","year":"2004","unstructured":"Chatila TA. Interleukin-4 receptor signaling pathways in asthma pathogenesis. Trends Mol Med. 2004;10:493\u20139. https:\/\/doi.org\/10.1016\/j.molmed.2004.08.004.","journal-title":"Trends Mol Med"},{"key":"1991_CR10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1146\/annurev.immunol.17.1.701","volume":"17","author":"K Nelms","year":"1999","unstructured":"Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999;17:701\u201338. https:\/\/doi.org\/10.1146\/annurev.immunol.17.1.701.","journal-title":"Annu Rev Immunol"},{"key":"1991_CR11","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.4049\/jimmunol.161.4.1811","volume":"161","author":"JJ Ryan","year":"1998","unstructured":"Ryan JJ, McReynolds LJ, Huang H, Nelms K, Paul WE. Characterization of a mobile Stat6 activation motif in the human IL-4 receptor. J Immunol. 1998;161:1811\u201321.","journal-title":"J Immunol"},{"key":"1991_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1084\/jem.20020903","volume":"197","author":"MG Chiaramonte","year":"2003","unstructured":"Chiaramonte MG, et al. Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J Exp Med. 2003;197:687\u2013701. https:\/\/doi.org\/10.1084\/jem.20020903.","journal-title":"J Exp Med"},{"key":"1991_CR13","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","volume":"378","author":"M Castro","year":"2018","unstructured":"Castro M, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med. 2018;378:2486\u201396. https:\/\/doi.org\/10.1056\/NEJMoa1804092.","journal-title":"N Engl J Med"},{"key":"1991_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.chest.2022.01.071","volume":"162","author":"LD Sher","year":"2022","unstructured":"Sher LD, et al. Dupilumab reduces oral corticosteroid use in patients with corticosteroid-dependent severe asthma: an analysis of the phase 3. Open-Label Extens TRAVERSE Trial Chest. 2022;162:46\u201355. https:\/\/doi.org\/10.1016\/j.chest.2022.01.071.","journal-title":"Open-Label Extens TRAVERSE Trial Chest"},{"key":"1991_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jdcr.2022.12.009","volume":"32","author":"C Zhu","year":"2023","unstructured":"Zhu C, Fok JS, Lin L, Su H, Maurer M. Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab. JAAD Case Rep. 2023;32:109\u201312. https:\/\/doi.org\/10.1016\/j.jdcr.2022.12.009.","journal-title":"JAAD Case Rep"},{"key":"1991_CR16","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00239-2023","author":"A Agusti","year":"2023","unstructured":"Agusti A, et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Eur Respir J. 2023. https:\/\/doi.org\/10.1183\/13993003.00239-2023.","journal-title":"Eur Respir J"},{"key":"1991_CR17","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1172\/JCI80911","volume":"125","author":"M Raundhal","year":"2015","unstructured":"Raundhal M, et al. High IFN-gamma and low SLPI mark severe asthma in mice and humans. J Clin Invest. 2015;125:3037\u201350. https:\/\/doi.org\/10.1172\/JCI80911.","journal-title":"J Clin Invest"},{"key":"1991_CR18","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1084\/jem.185.9.1671","volume":"185","author":"S Tsuyuki","year":"1997","unstructured":"Tsuyuki S, Tsuyuki J, Einsle K, Kopf M, Coyle AJ. Costimulation through B7\u20132 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp Med. 1997;185:1671\u20139. https:\/\/doi.org\/10.1084\/jem.185.9.1671.","journal-title":"J Exp Med"},{"key":"1991_CR19","doi-asserted-by":"publisher","first-page":"L833","DOI":"10.1152\/ajplung.00173.2001","volume":"282","author":"DS Southam","year":"2002","unstructured":"Southam DS, Dolovich M, O\u2019Byrne PM, Inman MD. Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am J Physiol Lung Cell Mol Physiol. 2002;282:L833-839. https:\/\/doi.org\/10.1152\/ajplung.00173.2001.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1991_CR20","doi-asserted-by":"publisher","first-page":"L204","DOI":"10.1152\/ajplung.00470.2020","volume":"321","author":"A Robichaud","year":"2021","unstructured":"Robichaud A, et al. Airway compliance measurements in mouse models of respiratory diseases. Am J Physiol Lung Cell Mol Physiol. 2021;321:L204\u201312. https:\/\/doi.org\/10.1152\/ajplung.00470.2020.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1991_CR21","doi-asserted-by":"publisher","DOI":"10.14440\/jbm.2017.174","volume":"4","author":"K Dua","year":"2017","unstructured":"Dua K, Shukla SD, Hansbro PM. Aspiration techniques for bronchoalveolar lavage in translational respiratory research: Paving the way to develop novel therapeutic moieties. J Biol Methods. 2017;4: e73. https:\/\/doi.org\/10.14440\/jbm.2017.174.","journal-title":"J Biol Methods"},{"key":"1991_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.4103\/1947-2714.100998","volume":"4","author":"T Mahmood","year":"2012","unstructured":"Mahmood T, Yang PC. Western blot: technique, theory, and trouble shooting. N Am J Med Sci. 2012;4:429\u201334. https:\/\/doi.org\/10.4103\/1947-2714.100998.","journal-title":"N Am J Med Sci"},{"key":"1991_CR23","doi-asserted-by":"publisher","first-page":"010502","DOI":"10.11613\/bm.2021.010502","volume":"31","author":"CC Serdar","year":"2021","unstructured":"Serdar CC, Cihan M, Y\u00fccel D, Serdar MA. Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies. Biochem Med (Zagreb). 2021;31:010502. https:\/\/doi.org\/10.11613\/bm.2021.010502.","journal-title":"Biochem Med (Zagreb)"},{"key":"1991_CR24","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/brm.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41:1149\u201360. https:\/\/doi.org\/10.3758\/brm.41.4.1149.","journal-title":"Behav Res Methods"},{"key":"1991_CR25","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1016\/j.jaip.2022.05.019","volume":"10","author":"ME Wechsler","year":"2022","unstructured":"Wechsler ME, et al. Effect of dupilumab on blood eosinophil counts in patients with asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, or eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2022;10:2695\u2013709. https:\/\/doi.org\/10.1016\/j.jaip.2022.05.019.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1991_CR26","doi-asserted-by":"publisher","first-page":"107839","DOI":"10.1016\/j.pharmthera.2021.107839","volume":"225","author":"G Liu","year":"2021","unstructured":"Liu G, et al. Therapeutic targets in lung tissue remodelling and fibrosis. Pharmacol Ther. 2021;225:107839. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107839.","journal-title":"Pharmacol Ther"},{"key":"1991_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s10020-021-00283-6","volume":"27","author":"H Ding","year":"2021","unstructured":"Ding H, Chen J, Qin J, Chen R, Yi Z. TGF-beta-induced alpha-SMA expression is mediated by C\/EBPbeta acetylation in human alveolar epithelial cells. Mol Med. 2021;27:22. https:\/\/doi.org\/10.1186\/s10020-021-00283-6.","journal-title":"Mol Med"},{"key":"1991_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1183\/09031936.00147807","volume":"32","author":"BB Araujo","year":"2008","unstructured":"Araujo BB, et al. Extracellular matrix components and regulators in the airway smooth muscle in asthma. Eur Respir J. 2008;32:61\u20139. https:\/\/doi.org\/10.1183\/09031936.00147807.","journal-title":"Eur Respir J"},{"key":"1991_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810546","author":"HS Lee","year":"2022","unstructured":"Lee HS, Kim WJ. The role of matrix metalloproteinase in inflammation with a focus on infectious diseases. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms231810546.","journal-title":"Int J Mol Sci"},{"key":"1991_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2174\/1568010053586246","volume":"4","author":"H Ohbayashi","year":"2005","unstructured":"Ohbayashi H, Shimokata K. Matrix metalloproteinase-9 and airway remodeling in asthma. Curr Drug Targets Inflamm Allergy. 2005;4:177\u201381. https:\/\/doi.org\/10.2174\/1568010053586246.","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"1991_CR31","first-page":"12","volume":"1","author":"B Mdkhana","year":"2024","unstructured":"Mdkhana B, Saheb Sharif-Askari N, Cagliani R, Al-Sheakly BKS, Ramakrishnan RK, Saheb Sharif-Askari F, Hachim IY, Hamid Q, Rawas-Qalaji M, Halwani R. Inhibiting DNA sensing pathway controls steroid hyporesponsive lung\u00a0inflammation. Adv Biol. 2024;1:12.","journal-title":"Adv Biol"},{"key":"1991_CR32","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s00011-024-01937-x","volume":"73","author":"N Saheb Sharif-Askari","year":"2024","unstructured":"Saheb Sharif-Askari N, et al. Calprotectin is regulated by IL-17A and induces steroid hyporesponsiveness in asthma. Inflamm Res. 2024;73:1875\u201388. https:\/\/doi.org\/10.1007\/s00011-024-01937-x.","journal-title":"Inflamm Res"},{"key":"1991_CR33","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0096-2019","author":"R Wadhwa","year":"2019","unstructured":"Wadhwa R, et al. Cellular mechanisms underlying steroid-resistant asthma. Eur Respir Rev. 2019. https:\/\/doi.org\/10.1183\/16000617.0096-2019.","journal-title":"Eur Respir Rev"},{"key":"1991_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40169-020-0262-5","volume":"9","author":"J Bi","year":"2020","unstructured":"Bi J, et al. PI3K inhibitor treatment ameliorates the glucocorticoid insensitivity of PBMCs in severe asthma. Clin Transl Med. 2020;9:22. https:\/\/doi.org\/10.1186\/s40169-020-0262-5.","journal-title":"Clin Transl Med"},{"key":"1991_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1164\/rccm.200305-659OC","volume":"170","author":"BG Cosio","year":"2004","unstructured":"Cosio BG, et al. Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. Am J Respir Crit Care Med. 2004;170:141\u20137. https:\/\/doi.org\/10.1164\/rccm.200305-659OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1991_CR36","doi-asserted-by":"publisher","first-page":"111137","DOI":"10.1016\/j.intimp.2023.111137","volume":"125","author":"S Deng","year":"2023","unstructured":"Deng S, et al. Dupilumab and subcutaneous immunotherapy for the treatment of refractory moderate to severe atopic dermatitis: a preliminary report. Int Immunopharmacol. 2023;125:111137. https:\/\/doi.org\/10.1016\/j.intimp.2023.111137.","journal-title":"Int Immunopharmacol"},{"key":"1991_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11095-019-2745-x","volume":"37","author":"A Al Shoyaib","year":"2019","unstructured":"Al Shoyaib A, Archie SR, Karamyan VT. Intraperitoneal route of drug administration: Should it be used in experimental animal studies? Pharm Res. 2019;37:12. https:\/\/doi.org\/10.1007\/s11095-019-2745-x.","journal-title":"Pharm Res"},{"key":"1991_CR38","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.xphs.2018.01.007","volume":"107","author":"MR Turner","year":"2018","unstructured":"Turner MR, Balu-Iyer SV. Challenges and opportunities for the subcutaneous delivery of therapeutic proteins. J Pharm Sci. 2018;107:1247\u201360. https:\/\/doi.org\/10.1016\/j.xphs.2018.01.007.","journal-title":"J Pharm Sci"},{"key":"1991_CR39","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/iid3.405","volume":"9","author":"GP Xi","year":"2021","unstructured":"Xi GP, Zhang Q, Yin J. Establishment and characterization of murine models of asthma and subcutaneous immunotherapy for Humulus pollen allergy. Immun Inflamm Dis. 2021;9:443\u201355. https:\/\/doi.org\/10.1002\/iid3.405.","journal-title":"Immun Inflamm Dis"},{"key":"1991_CR40","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.pharmthera.2012.03.003","volume":"134","author":"S Grassin-Delyle","year":"2012","unstructured":"Grassin-Delyle S, et al. Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Pharmacol Ther. 2012;134:366\u201379. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.03.003.","journal-title":"Pharmacol Ther"},{"key":"1991_CR41","doi-asserted-by":"publisher","first-page":"288","DOI":"10.18433\/j3nc79","volume":"12","author":"A Pires","year":"2009","unstructured":"Pires A, Fortuna A, Alves G, Falcao A. Intranasal drug delivery: how, why and what for? J Pharm Pharm Sci. 2009;12:288\u2013311. https:\/\/doi.org\/10.18433\/j3nc79.","journal-title":"J Pharm Pharm Sci"},{"key":"1991_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.89","volume":"48","author":"R Halwani","year":"2016","unstructured":"Halwani R, et al. A novel anti-IL4Ralpha nanoparticle efficiently controls lung inflammation during asthma. Exp Mol Med. 2016;48: e262. https:\/\/doi.org\/10.1038\/emm.2016.89.","journal-title":"Exp Mol Med"},{"key":"1991_CR43","first-page":"1","volume":"20","author":"W Fokkens","year":"2007","unstructured":"Fokkens W, Lund V, Mullol J. European position paper on, R. & nasal polyps, g. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl. 2007;20:1\u2013136.","journal-title":"Rhinol Suppl"},{"key":"1991_CR44","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/all.12124","volume":"68","author":"S Lohia","year":"2013","unstructured":"Lohia S, Schlosser RJ, Soler ZM. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis. Allergy. 2013;68:569\u201379. https:\/\/doi.org\/10.1111\/all.12124.","journal-title":"Allergy"},{"key":"1991_CR45","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.jaip.2020.09.014","volume":"9","author":"C M\u00fcmmler","year":"2021","unstructured":"M\u00fcmmler C, et al. Dupilumab improves asthma control and lung function in patients with insufficient outcome during previous antibody therapy. J Allergy Clin Immunol Pract. 2021;9:1177-1185.e1174. https:\/\/doi.org\/10.1016\/j.jaip.2020.09.014.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1991_CR46","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/all.14151","volume":"75","author":"A Le Floc'h","year":"2020","unstructured":"Le Floc\u2019h A, et al. Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4R\u03b1 antibody, is required to broadly inhibit type 2 inflammation. Allergy. 2020;75:1188\u2013204. https:\/\/doi.org\/10.1111\/all.14151.","journal-title":"Allergy"},{"key":"1991_CR47","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1002\/eji.201242433","volume":"42","author":"E Maier","year":"2012","unstructured":"Maier E, Duschl A, Horejs-Hoeck J. STAT6-dependent and -independent mechanisms in Th2 polarization. Eur J Immunol. 2012;42:2827\u201333. https:\/\/doi.org\/10.1002\/eji.201242433.","journal-title":"Eur J Immunol"},{"key":"1991_CR48","doi-asserted-by":"publisher","first-page":"10495","DOI":"10.1038\/s41598-021-89860-7","volume":"11","author":"LP Deimel","year":"2021","unstructured":"Deimel LP, Li Z, Roy S, Ranasinghe C. STAT3 determines IL-4 signalling outcomes in na\u00efve T cells. Sci Rep. 2021;11:10495. https:\/\/doi.org\/10.1038\/s41598-021-89860-7.","journal-title":"Sci Rep"},{"key":"1991_CR49","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.immuni.2010.05.003","volume":"32","author":"L Durant","year":"2010","unstructured":"Durant L, et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity. 2010;32:605\u201315. https:\/\/doi.org\/10.1016\/j.immuni.2010.05.003.","journal-title":"Immunity"},{"key":"1991_CR50","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.1073\/pnas.0600666103","volume":"103","author":"Z Chen","year":"2006","unstructured":"Chen Z, et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci U S A. 2006;103:8137\u201342. https:\/\/doi.org\/10.1073\/pnas.0600666103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1991_CR51","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18:1028\u201340. https:\/\/doi.org\/10.1038\/nm.2807.","journal-title":"Nat Med"},{"key":"1991_CR52","doi-asserted-by":"publisher","first-page":"G950","DOI":"10.1152\/ajpgi.00132.2011","volume":"301","author":"TN Wight","year":"2011","unstructured":"Wight TN, Potter-Perigo S. The extracellular matrix: an active or passive player in fibrosis? Am J Physiol Gastrointest Liver Physiol. 2011;301:G950-955. https:\/\/doi.org\/10.1152\/ajpgi.00132.2011.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1991_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nm1332","volume":"12","author":"S Fichtner-Feigl","year":"2006","unstructured":"Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med. 2006;12:99\u2013106. https:\/\/doi.org\/10.1038\/nm1332.","journal-title":"Nat Med"},{"key":"1991_CR54","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cyto.2015.05.014","volume":"75","author":"N Gour","year":"2015","unstructured":"Gour N, Wills-Karp M. IL-4 and IL-13 signaling in allergic airway disease. Cytokine. 2015;75:68\u201378. https:\/\/doi.org\/10.1016\/j.cyto.2015.05.014.","journal-title":"Cytokine"},{"key":"1991_CR55","doi-asserted-by":"publisher","first-page":"300060520919592","DOI":"10.1177\/0300060520919592","volume":"48","author":"G Chen","year":"2020","unstructured":"Chen G, Ge D, Zhu B, Shi H, Ma Q. Upregulation of matrix metalloproteinase 9 (MMP9)\/tissue inhibitor of metalloproteinase 1 (TIMP1) and MMP2\/TIMP2 ratios may be involved in lipopolysaccharide-induced acute lung injury. J Int Med Res. 2020;48:300060520919592. https:\/\/doi.org\/10.1177\/0300060520919592.","journal-title":"J Int Med Res"},{"key":"1991_CR56","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.3389\/fimmu.2018.02781","volume":"9","author":"SD Kamdem","year":"2018","unstructured":"Kamdem SD, Moyou-Somo R, Brombacher F, Nono JK. Host regulators of liver fibrosis during human schistosomiasis. Front Immunol. 2018;9:2781. https:\/\/doi.org\/10.3389\/fimmu.2018.02781.","journal-title":"Front Immunol"},{"key":"1991_CR57","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","volume":"378","author":"KF Rabe","year":"2018","unstructured":"Rabe KF, et al. Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med. 2018;378:2475\u201385. https:\/\/doi.org\/10.1056\/NEJMoa1804093.","journal-title":"N Engl J Med"},{"key":"1991_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-024-00654-w","author":"T Gover","year":"2024","unstructured":"Gover T, Slezak M. Targeting glucocorticoid receptor signaling pathway for treatment of stress-related brain disorders. Pharmacol Rep. 2024. https:\/\/doi.org\/10.1007\/s43440-024-00654-w.","journal-title":"Pharmacol Rep"},{"key":"1991_CR59","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jaci.2012.12.1564","volume":"131","author":"PJ Barnes","year":"2013","unstructured":"Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2013;131:636\u201345. https:\/\/doi.org\/10.1016\/j.jaci.2012.12.1564.","journal-title":"J Allergy Clin Immunol"},{"key":"1991_CR60","doi-asserted-by":"publisher","first-page":"9565","DOI":"10.1038\/s41598-017-09869-9","volume":"7","author":"L Panda","year":"2017","unstructured":"Panda L, et al. Linoleic acid metabolite leads to steroid resistant asthma features partially through NF-kappaB. Sci Rep. 2017;7:9565. https:\/\/doi.org\/10.1038\/s41598-017-09869-9.","journal-title":"Sci Rep"},{"key":"1991_CR61","doi-asserted-by":"publisher","first-page":"L269","DOI":"10.1152\/ajplung.00143.2018","volume":"316","author":"T Lai","year":"2019","unstructured":"Lai T, et al. HDAC2 attenuates airway inflammation by suppressing IL-17A production in HDM-challenged mice. Am J Physiol Lung Cell Mol Physiol. 2019;316:L269\u201379. https:\/\/doi.org\/10.1152\/ajplung.00143.2018.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1991_CR62","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.3389\/fimmu.2020.01724","volume":"11","author":"S Al Heialy","year":"2020","unstructured":"Al Heialy S, et al. Contribution of IL-17 in steroid hyporesponsiveness in obese asthmatics through dysregulation of glucocorticoid receptors alpha and beta. Front Immunol. 2020;11:1724. https:\/\/doi.org\/10.3389\/fimmu.2020.01724.","journal-title":"Front Immunol"},{"key":"1991_CR63","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jaip.2019.07.016","volume":"8","author":"JF Maspero","year":"2020","unstructured":"Maspero JF, et al. Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2020;8:527-539e529. https:\/\/doi.org\/10.1016\/j.jaip.2019.07.016.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1991_CR64","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.jaip.2022.03.020","volume":"10","author":"C Domingo","year":"2022","unstructured":"Domingo C, et al. Dupilumab efficacy in steroid-dependent severe asthma by baseline oral corticosteroid dose. J Allergy Clin Immunol Pract. 2022;10:1835\u201343. https:\/\/doi.org\/10.1016\/j.jaip.2022.03.020.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1991_CR65","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1242\/dmm.000323","volume":"1","author":"AT Nials","year":"2008","unstructured":"Nials AT, Uddin S. Mouse models of allergic asthma: acute and chronic allergen challenge. Dis Model Mech. 2008;1:213\u201320. https:\/\/doi.org\/10.1242\/dmm.000323.","journal-title":"Dis Model Mech"},{"key":"1991_CR66","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/resp.12315","volume":"19","author":"RA Martin","year":"2014","unstructured":"Martin RA, Hodgkins SR, Dixon AE, Poynter ME. Aligning mouse models of asthma to human endotypes of disease. Respirology. 2014;19:823\u201333. https:\/\/doi.org\/10.1111\/resp.12315.","journal-title":"Respirology"},{"key":"1991_CR67","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.it.2016.12.007","volume":"38","author":"L Tao","year":"2017","unstructured":"Tao L, Reese TA. Making mouse models that reflect human immune responses. Trends Immunol. 2017;38:181\u201393. https:\/\/doi.org\/10.1016\/j.it.2016.12.007.","journal-title":"Trends Immunol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-024-01991-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-024-01991-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-024-01991-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:52:35Z","timestamp":1767199955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-024-01991-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1991"],"URL":"https:\/\/doi.org\/10.1007\/s00011-024-01991-5","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"43"}}